Search - tctmd.com

Displaying 261 - 280 of 450

Sort: Relevancy | Date

Presentation TCT 2019

Impella-Facilitated, IVUS-Guided Left Main With Double CTO Revascularisation in NSTEMI With Severe LV Impairment and Severe Ischaemic Mitral Regurgitation

Presenter: Kalaivani Mahadevan, MD

September 27, 2019

Presentation TCT 2019

Double Indication for Impella CP: High-Risk Percutaneous Coronary Intervention (PCI) and Acute Myocardial Infarction Complicated by Cardiogenic Shock (AMICS)

Presenter: Rafael Ferreira

September 27, 2019

Presentation TCT 2019

Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of Life

Presenter: Ehtisham Mahmud

September 26, 2019

Presentation TCT 2019

The Value of Complete Revascularization in a Single Setting

Presenter: Rajan Patel

September 26, 2019

Presentation TCT 2019

Protected PCI: A Contemporary Look at Clinical Data from cVAD

Presenter: Jeffrey Popma

September 26, 2019

News Conference News TCT 2019

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Todd Neale

September 25, 2019

News CV Team Pro

The Providence St. Vincent Medical Center Cath Lab Team

L.A. McKeown

September 12, 2019

Presentation TVT 2019

Life-Saving Procedure Planning: Predicted Coronary Occlusion and Impella Bailout in Valve-in-Valve Transcatheter Aortic Valve Replacement

Presenter: Luis Dallan

June 13, 2019

News Conference News EuroPCR 2019

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Caitlin E. Cox

June 05, 2019

News Conference News SCAI 2019

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Yael L. Maxwell

May 31, 2019

News Daily News

FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting

Todd Neale

May 21, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

Presentation ARCH 2019

Best case or worst case?

Presenter: Neville F. Mistry

April 11, 2019

Presentation

IMPELLA vs Intra-Aortic Balloon PumpA Reflective Perspective

Presenter: David Cox

April 11, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

Presentation SIF 2019

My Favorite Mechanical Circulatory Support Case

Presenter: Manish A. Parikh

March 29, 2019

Presentation SIF 2019

Novel Complex Procedures and Devices: The “Known and known Unknowns "

Presenter: Morton J. Kern

March 29, 2019

Advertisement

Impella-Facilitated, IVUS-Guided Left Main With Double CTO Revascularisation in NSTEMI With Severe LV Impairment and Severe Ischaemic Mitral Regurgitation

Double Indication for Impella CP: High-Risk Percutaneous Coronary Intervention (PCI) and Acute Myocardial Infarction Complicated by Cardiogenic Shock (AMICS)

Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of Life

The Value of Complete Revascularization in a Single Setting

Protected PCI: A Contemporary Look at Clinical Data from cVAD

Strokes Increasing in STEMI Patients With Cardiogenic Shock

The Providence St. Vincent Medical Center Cath Lab Team

Life-Saving Procedure Planning: Predicted Coronary Occlusion and Impella Bailout in Valve-in-Valve Transcatheter Aortic Valve Replacement

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Best case or worst case?

IMPELLA vs Intra-Aortic Balloon PumpA Reflective Perspective

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

My Favorite Mechanical Circulatory Support Case

Novel Complex Procedures and Devices: The “Known and known Unknowns "

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content